Skip to content

Screener

Eligibility screening

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Sponsored by Theravectys S.A.Study detailsClinicalTrials.gov

4 US sites in FL, OK

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.